CA3131485A1 - Composition for improving the culture and implantation of mammalian embryos,preparation method and use thereof - Google Patents
Composition for improving the culture and implantation of mammalian embryos,preparation method and use thereof Download PDFInfo
- Publication number
- CA3131485A1 CA3131485A1 CA3131485A CA3131485A CA3131485A1 CA 3131485 A1 CA3131485 A1 CA 3131485A1 CA 3131485 A CA3131485 A CA 3131485A CA 3131485 A CA3131485 A CA 3131485A CA 3131485 A1 CA3131485 A1 CA 3131485A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- fraction
- embryos
- culture
- embryo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 93
- 210000001161 mammalian embryo Anatomy 0.000 title claims abstract description 61
- 238000002513 implantation Methods 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 33
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 21
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 17
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 17
- 102000006734 Beta-Globulins Human genes 0.000 claims abstract description 9
- 108010087504 Beta-Globulins Proteins 0.000 claims abstract description 9
- 108010074605 gamma-Globulins Proteins 0.000 claims abstract description 9
- 238000005194 fractionation Methods 0.000 claims abstract description 7
- 239000001963 growth medium Substances 0.000 claims description 20
- 239000006228 supernatant Substances 0.000 claims description 15
- 238000011026 diafiltration Methods 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 239000000543 intermediate Substances 0.000 claims description 3
- 238000005352 clarification Methods 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000001728 nano-filtration Methods 0.000 claims description 2
- 238000009928 pasteurization Methods 0.000 claims description 2
- 244000052769 pathogen Species 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 238000000108 ultra-filtration Methods 0.000 claims description 2
- 210000002257 embryonic structure Anatomy 0.000 description 44
- 210000002459 blastocyst Anatomy 0.000 description 22
- 239000002609 medium Substances 0.000 description 9
- 210000002381 plasma Anatomy 0.000 description 9
- 238000000338 in vitro Methods 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 108010044091 Globulins Proteins 0.000 description 6
- 102000006395 Globulins Human genes 0.000 description 6
- 230000013020 embryo development Effects 0.000 description 5
- 230000032692 embryo implantation Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000012447 hatching Effects 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 208000002352 blister Diseases 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 231100001075 aneuploidy Toxicity 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000000942 confocal micrograph Methods 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000010448 genetic screening Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000472 morula Anatomy 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000002993 trophoblast Anatomy 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- 230000002034 xenobiotic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0604—Whole embryos; Culture medium therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382106.3 | 2019-02-15 | ||
| EP19382106.3A EP3696260A1 (en) | 2019-02-15 | 2019-02-15 | Composition for improving the culture and implantation of mammalian embryos, preparation method and use thereof |
| PCT/EP2020/053548 WO2020165218A1 (en) | 2019-02-15 | 2020-02-12 | Composition for improving the culture and implantation of mammalian embryos,preparation method and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3131485A1 true CA3131485A1 (en) | 2020-08-20 |
Family
ID=65529628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3131485A Pending CA3131485A1 (en) | 2019-02-15 | 2020-02-12 | Composition for improving the culture and implantation of mammalian embryos,preparation method and use thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220073871A1 (ja) |
| EP (2) | EP3696260A1 (ja) |
| JP (1) | JP2022520552A (ja) |
| KR (1) | KR20210128405A (ja) |
| CN (1) | CN113423819A (ja) |
| AR (1) | AR118063A1 (ja) |
| AU (1) | AU2020220372A1 (ja) |
| CA (1) | CA3131485A1 (ja) |
| TW (1) | TW202043461A (ja) |
| UY (1) | UY38579A (ja) |
| WO (1) | WO2020165218A1 (ja) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4156681A (en) * | 1974-03-28 | 1979-05-29 | Plasmesco Ag | Process for isolating albumin from blood |
| CN1847393A (zh) * | 2000-06-09 | 2006-10-18 | 维特罗莱夫公司 | 添加剂，制剂和培养基 |
| ES2360782B1 (es) * | 2009-07-28 | 2012-03-12 | Grifols, S.A. | Medios para cultivo de células de mamíferos que comprenden sobrenadante de etapas del fraccionamiento de Cohn y uso de los mismos. |
| US10213282B2 (en) | 2014-04-28 | 2019-02-26 | California Institute Of Technology | In vitro platform and methods for culturing embryos for implantation |
-
2019
- 2019-02-15 EP EP19382106.3A patent/EP3696260A1/en not_active Withdrawn
-
2020
- 2020-02-12 AU AU2020220372A patent/AU2020220372A1/en active Pending
- 2020-02-12 CA CA3131485A patent/CA3131485A1/en active Pending
- 2020-02-12 KR KR1020217026040A patent/KR20210128405A/ko unknown
- 2020-02-12 US US17/310,573 patent/US20220073871A1/en active Pending
- 2020-02-12 WO PCT/EP2020/053548 patent/WO2020165218A1/en unknown
- 2020-02-12 UY UY0001038579A patent/UY38579A/es unknown
- 2020-02-12 CN CN202080013862.1A patent/CN113423819A/zh active Pending
- 2020-02-12 JP JP2021546016A patent/JP2022520552A/ja active Pending
- 2020-02-12 EP EP20703264.0A patent/EP3924466A1/en active Pending
- 2020-02-13 AR ARP200100377A patent/AR118063A1/es unknown
- 2020-02-14 TW TW109104768A patent/TW202043461A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3924466A1 (en) | 2021-12-22 |
| AU2020220372A1 (en) | 2021-08-12 |
| EP3696260A1 (en) | 2020-08-19 |
| TW202043461A (zh) | 2020-12-01 |
| WO2020165218A1 (en) | 2020-08-20 |
| UY38579A (es) | 2020-09-30 |
| JP2022520552A (ja) | 2022-03-31 |
| KR20210128405A (ko) | 2021-10-26 |
| AR118063A1 (es) | 2021-09-15 |
| CN113423819A (zh) | 2021-09-21 |
| US20220073871A1 (en) | 2022-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gardner et al. | Culture of viable human blastocysts in defined sequential serum-free media | |
| Mikkelsen | Strategies in human in-vitro maturation and their clinical outcome | |
| Nagy et al. | Timing of oocyte activation, pronucleus formation and cleavage in humans after intracytoplasmic sperm injection (ICSI) with testicular spermatozoa and after ICSI or in-vitro fertilization on sibling oocytes with ejaculated spermatozoa. | |
| Vernaeve et al. | Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia | |
| Wiemer et al. | Coculture of human zygotes on fetal bovine uterine fibroblasts: embryonic morphology and implantation | |
| Nagy et al. | Time-course of oocyte activation, pronucleus formation and cleavage in human oocytes fertilized by intracytoplasmic sperm injection | |
| Fishel et al. | Subzonal insemination for the alleviation of infertility | |
| Svalander et al. | Factors of importance for the establishment of a successful program of intracytoplasmic sperm injection treatment for male infertility | |
| US11957384B2 (en) | Method of producing a peripheral blood mononuclear cell composition suitable for repairing or engineering a tissue | |
| KR20090042816A (ko) | 망막 줄기 세포로부터 유래한 합성 각막 | |
| Wang et al. | Development of porcine embryos produced by IVM/IVF in a medium with or without protein supplementation: effects of extracellular glutathione | |
| Holden et al. | Frozen-thawed epididymal spermatozoa for intracytoplasmic sperm injection | |
| Meintjes | Media composition: macromolecules and embryo growth | |
| Wiemer et al. | The application of co-culture in assisted reproduction: 10 years of experience with human embryos | |
| US8759288B2 (en) | Blastocyst culture supernatant as a fertility agent in blastocyst transfer | |
| Verheyen et al. | Simple and reliable identification of the human round spermatid by inverted phase-contrast microscopy. | |
| Mikkelsen et al. | Maternal serum supplementation in culture medium benefits maturation of immature human oocytes | |
| US20220073871A1 (en) | Composition for improving the culture and implantation of mammalian embryos, preparation method and use thereof | |
| Ashwood-Smith et al. | The use of Albuminar 5 (TM) as a medium supplement in clinical FVF | |
| US20020115211A1 (en) | A method for in vitro maturation of human gametes | |
| Lee et al. | Establishment of a basic method for manipulating preantral follicles: effects of retrieval method on in vitro growth of preantral follicles and intrafollicular oocytes | |
| as a Transfer et al. | Effect of embryo glue as a transfer medium in the outcome of implantation rate and live birth rate in freeze-thaw embryo transfer cycles | |
| Trounson | Spindle abnormalities in oocytes | |
| Gianaroli et al. | Human amniotic fluid for fertilization and culture of human embryos: Results of clinical trials in human in vitro fertilization (IVF) programs | |
| Karagouga et al. | Conventional IVF with short co-incubation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220919 |
|
| EEER | Examination request |
Effective date: 20220919 |
|
| EEER | Examination request |
Effective date: 20220919 |
|
| EEER | Examination request |
Effective date: 20220919 |
|
| EEER | Examination request |
Effective date: 20220919 |